Evolving a Strategic Approach to Cervical Cancer Control in Africa

Overview

Journal Gynecol Oncol

Date 2005 Oct 6

PMID 16202445

Citations 14

Authors

Isaac F Adewole

J L Benedet

Brian T Crain

Michele Follen

Affiliations

Soon will be listed here.

Abstract

Nigeria is a country in Western Africa where the incidence rate of cervical cancer is 25/100,000. There are 32 million women aged 15-64 years old. If we were to conduct a one-time screen over 1 year, 8000 new invasive cervical cancers would be detected. Currently, 80% of cases present in Stage III. While a one-time screen should detect some earlier stages, there could be as many as 6400 Stage III cancers to treat. Strategies to enable a one-time screen are being considered.

Citing Articles

Stated preferences for human papillomavirus vaccination for adolescents in selected communities in Ibadan, Southwest Nigeria: A discrete choice experiment.

Balogun F, Omotade O, Svensson M Hum Vaccin Immunother. 2022; 18(6):2124091.

PMID: 36383765 PMC: 9746423. DOI: 10.1080/21645515.2022.2124091.

Cancer in sub-Saharan Africa: a Lancet Oncology Commission.

Ngwa W, Addai B, Adewole I, Ainsworth V, Alaro J, Alatise O Lancet Oncol. 2022; 23(6):e251-e312.

PMID: 35550267 PMC: 9393090. DOI: 10.1016/S1470-2045(21)00720-8.

Evaluation of oxidative markers in women with invasive cervical cancer in Lagos, Nigeria.

Offor J, Okunade K, Iwalokun B, Oluwole A, Anorlu R Ecancermedicalscience. 2021; 15:1266.

PMID: 34567251 PMC: 8426022. DOI: 10.3332/ecancer.2021.1266.

Women's knowledge and attitude towards cervical cancer preventive measures and associated factors In South Gondar Zone, Amhara Region, North Central Ethiopia: a cross-sectional study.

Tafere Y, Jemere T, Desalegn T, Melak A Arch Public Health. 2021; 79(1):136.

PMID: 34301336 PMC: 8299606. DOI: 10.1186/s13690-021-00659-4.

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay.

Rantshabeng P, Kasvosve I, Ndlovu A, Gaseitsiwe S, Moyo S PLoS One. 2019; 14(1):e0211260.

PMID: 30699172 PMC: 6353155. DOI: 10.1371/journal.pone.0211260.